Related Experiment Video
Updated: May 23, 2026
07:22
Quality-Controlled Sputum Analysis by Flow Cytometry
Published on: August 9, 2021
Emerging applications of flow cytometry in solid tumor biology
1Research Division, Ontario Cancer Institute and Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9.
Methods (San Diego, Calif.)
|April 17, 2012
Summary
Flow cytometry, a powerful tool for analyzing cell populations, is re-emerging for solid tumor research. Advances in technology and data analysis highlight its potential for understanding cancer biology and guiding molecular therapeutics.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Flow cytometry (FC) was initially promising for clinical development but saw reduced application in solid tumors.
- Recent advancements in cancer biology, molecular therapeutics, and FC technology warrant a re-evaluation of its role.
Purpose of the Study:
- To re-evaluate the application of flow cytometry in solid tumor analysis.
- To highlight the potential of FC in analyzing heterogeneous cell populations and functional regulatory processes.
Main Methods:
- Simultaneous measurement of multiple cellular elements using advanced FC instrumentation and reagents.
- Addressing challenges in clinical sample acquisition and tissue disaggregation for single-cell suspension.
- Developing protocols for labeling intracellular and cell surface antigens.
Main Results:
- Flow cytometry offers unique potential for analyzing complex cellular heterogeneity in solid tumors.
- Simultaneous multi-parameter analysis provides insights into functional regulatory processes.
- Overcoming technical and logistical hurdles is key to successful FC application.
Conclusions:
- Flow cytometry presents a valuable approach for solid tumor research, offering deep insights into cellular heterogeneity and function.
- Continued development in sampling, tissue processing, and multi-parameter analysis will enhance FC's utility in oncology.
- Revisiting and optimizing FC protocols can unlock its full potential in diagnosing and treating solid tumors.
